ADXN Addex Therapeutics Ltd ADRs

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SE:ADXN.

$10.36  -0.13 (-1.24%)
As of 04/14/2021 09:53:13 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  
IPO date:  01/29/2020
Outstanding shares:  6,624,773
Average volume:  8,064
Market cap:   $69,493,869
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -5.40
PB ratio:   4.76
PS ratio:   18.72
Return on equity:   -88.01%
Net income %:   -346.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy